We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+23.22%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$233B
AUM Growth
+$43B
Cap. Flow
+$3.65B
Cap. Flow %
1.56%
Top 10 Hldgs %
16.67%
Holding
3,808
New
183
Increased
1,548
Reduced
1,847
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 23.56%
2 Healthcare 12.1%
3 Financials 10.73%
4 Consumer Discretionary 8.24%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TK icon
3551
Teekay
TK
$996M
$78K ﹤0.01%
+32,385
New +$99.1K
MR
3552
DELISTED
Montage Resources Corporation Common Stock
MR
$78K ﹤0.01%
+19,845
New +$101K
CBB
3553
CALL
DELISTED
Cincinnati Bell Inc.
CBB
$77K ﹤0.01%
5,200
ALDX icon
3554
Aldeyra Therapeutics
ALDX
$97.1M
$76K ﹤0.01%
+18,453
New +$67.4K
MRCC
3555
DELISTED
Monroe Capital Corp
MRCC
$76K ﹤0.01%
10,875
-1,823
-14% -$13.4K
AVXL icon
3556
Anavex Life Sciences
AVXL
$231M
$74K ﹤0.01%
15,070
-1,735
-10% -$6.56K
HBIO icon
3557
Harvard Bioscience
HBIO
$27.6M
$74K ﹤0.01%
+2,400
New +$64.7K
CALA
3558
DELISTED
Calithera Biosciences, Inc
CALA
$73K ﹤0.01%
+692
New +$82.2K
BKCC
3559
DELISTED
BlackRock Capital Investment Corporation
BKCC
$71K ﹤0.01%
26,610
-8,402
-24% -$22.5K
NCMI icon
3560
National CineMedia
NCMI
$378M
$70K ﹤0.01%
2,318
-4,823
-68% -$145K
GYRE icon
3561
Gyre Therapeutics
GYRE
$629M
$67K ﹤0.01%
+1,512
New +$71K
TGS icon
3562
Transportadora de Gas del Sur
TGS
$4.48B
$67K ﹤0.01%
11,839
-13,718
-54% -$70K
NAGE
3563
Niagen Bioscience
NAGE
$256M
$64K ﹤0.01%
13,984
-5
-0% -$22
GALT icon
3564
Galectin Therapeutics
GALT
$230M
$62K ﹤0.01%
+20,199
New +$50.8K
CBAY
3565
DELISTED
Cymabay Therapeutics
CBAY
$60K ﹤0.01%
+17,021
New +$49.1K
CRK icon
3566
Comstock Resources
CRK
$3.7B
$57K ﹤0.01%
+13,019
New +$77.7K
CASI
3567
DELISTED
CASI Pharmaceuticals
CASI
$55K ﹤0.01%
2,207
+1
+0% +$22
KDNY
3568
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$54K ﹤0.01%
4,632
NMRK icon
3569
Newmark Group
NMRK
$2.64B
$53K ﹤0.01%
11,057
-439,207
-98% -$1.85M
NSL
3570
DELISTED
NUVEEN SENIOR INCM FD
NSL
$52K ﹤0.01%
11,158
+42
+0.4% +$192
HMHC
3571
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$51K ﹤0.01%
28,212
-110,519
-80% -$177K
AGEN
3572
Agenus
AGEN
$276M
$50K ﹤0.01%
651
+94
+17% +$5.63K
APTX
3573
DELISTED
Aptinyx Inc. Common Stock
APTX
$49K ﹤0.01%
+11,671
New +$39.5K
PMBC
3574
DELISTED
Pacific Mercantile Bancorp
PMBC
$48K ﹤0.01%
13,000
VATE icon
3575
INNOVATE Corp
VATE
$106M
$45K ﹤0.01%
1,330

Similar funds

Ameriprise's Q2 2020 Portfolio in Review

As of Q2 2020, Ameriprise held 3,808 positions worth $233B, up 23% from $190B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ameriprise's Q2 2020 filing shows 183 new, 1,548 increased, 1,847 reduced and 139 closed positions. Its largest new stake was Carrier Global: 9,308,867 shares worth $207M. The largest sale was Verizon, an estimated $393M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Ameriprise's largest Q2 2020 buy was Carrier Global: 9,308,867 shares worth $207M.
  • Ameriprise added most to TE Connectivity in Q2 2020, an estimated $479M increase.
  • Ameriprise's biggest Q2 2020 reduction was Verizon, cutting an estimated $393M.
  • Ameriprise fully exited Allergan plc in Q2 2020, selling an estimated $124M.
  • Ameriprise's ten largest holdings make up 17% of its $233B portfolio in Q2 2020.
  • Ameriprise opened 183 new positions and closed 139 in Q2 2020.
  • Ameriprise's portfolio value rose 23% quarter-over-quarter to $233B.

Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.